tirzepatide and lymphedema as a Potential Disease-Modifying Therapy in Lipedema: A Narrative Review on Bridging Metabolism, Inflammation, Fibrosis GLP-1 Medications, Weight Loss, and

The most common side effects are mild and go away on their own, such as: Nausea Vomiting Diarrhea Stomach pain Constipation Fatigue Dizziness Headache In rare cases, Semaglutide can cause more serious side effects, such as pancreatitis, cholelithiasis, kidney damage, and low blood sugar

Conclusion AOMs have the potential to meaningfully impact population mortality

Research suggests GLP-1 receptor agonists may slow aspects of CKD progression by reducing inflammation, improving metabolic health, and lowering albuminuria levels

This underlying risk factor should be considered when evaluating new dental problems that emerge during therapy

4 Stay Well Hydrated